Assyro AI

Orange Book product · Brand (NDA)

GENOSYL

NITRIC OXIDE

Brand (NDA)NDA 202860RX VERO BIOTECH INC

At a glance

Dec 20, 2019

Approved

Brand (NDA)

Application

Not listed

TE code

14

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 20, 2019

    6 yr 7 mo ago

  2. Patent 8057742 expires

    Listed method-of-use patent (U-3037) expiration.

    Jan 18, 2026

    5 mo ago

  3. Today

  4. Patent 7618594 expires

    Listed drug product patent expiration.

    Oct 17, 2026

    in 4 mo

  5. Patent 7947227 expires

    Listed method-of-use patent (U-3037) expiration.

    Oct 17, 2026

    in 4 mo

  6. Patent 7560076 expires

    Listed drug product patent expiration.

    Apr 21, 2027

    in 10 mo

  7. Patent 9701538 expires

    Listed drug product patent expiration.

    Jan 28, 2029

    in 2 yr 8 mo

  8. Patent 10926054 expires

    Listed drug product patent expiration.

    Aug 13, 2029

    in 3 yr 2 mo

  9. Patent 8944049 expires

    Listed drug product patent expiration.

    Aug 13, 2029

    in 3 yr 2 mo

  10. Patent 9604028 expires

    Listed method-of-use patent (U-2793) expiration.

    Aug 13, 2029

    in 3 yr 2 mo

  11. Patent 11511252 expires

    Listed drug product patent expiration.

    Sep 21, 2029

    in 3 yr 4 mo

  12. Patent 11103669 expires

    Listed drug product patent expiration.

    Jun 21, 2030

    in 4 yr 1 mo

  13. Patent 8607785 expires

    Listed drug product patent expiration.

    Jul 14, 2030

    in 4 yr 2 mo

  14. Patent 10737051 expires

    Listed drug product patent expiration.

    Oct 20, 2035

    in 9 yr 6 mo

  15. Patent 10213572 expires

    Listed drug product patent expiration.

    Feb 12, 2036

    in 9 yr 10 mo

  16. Patent 11672938 expires

    Listed method-of-use patent (U-3037) expiration.

    Jul 22, 2040

    in 14 yr 4 mo

Pharmaceutical detail

Active ingredient

NITRIC OXIDE

Strength

800PPM

Dosage form

GAS

Route

INHALATION

TE code

Not listed

Application

NDA 202860

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (14)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8057742Jan 18, 20265 mo ago
U-3037
7618594Oct 17, 2026in 4 mo
Product
7947227Oct 17, 2026in 4 mo
U-3037
7560076Apr 21, 2027in 10 mo
Product
9701538Jan 28, 2029in 2 yr 8 mo
Product
10926054Aug 13, 2029in 3 yr 2 mo
Product
8944049Aug 13, 2029in 3 yr 2 mo
Product
9604028Aug 13, 2029in 3 yr 2 mo
U-2793
11511252Sep 21, 2029in 3 yr 4 mo
Product
11103669Jun 21, 2030in 4 yr 1 mo
Product
8607785Jul 14, 2030in 4 yr 2 mo
Product
10737051Oct 20, 2035in 9 yr 6 mo
Product
10213572Feb 12, 2036in 9 yr 10 mo
Product
11672938Jul 22, 2040in 14 yr 4 mo
U-3037
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.